JY
TWST icon

Jeff Yass’s Twist Bioscience TWST Stock Holding History

Jeff Yass’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.99M Sell
87,400
-7,900
-8% -$514K ﹤0.01% 3567
2026
Q1 		$4.53M Buy
95,300
+56,200
+144% +$2.52M ﹤0.01% 4413
2025
Q4 		$1.24M Sell
39,100
-66,800
-63% -$2.08M ﹤0.01% 6682
2025
Q3 		$2.98M Buy
105,900
+77,700
+276% +$2.35M ﹤0.01% 4991
2025
Q2 		$1.04M Buy
28,200
+18,400
+188% +$636K ﹤0.01% 7336
2025
Q1 		$385K Sell
9,800
-43,300
-82% -$1.95M ﹤0.01% 9492
2024
Q4 		$2.47M Sell
53,100
-6,800
-11% -$307K ﹤0.01% 4839
2024
Q3 		$2.71M Sell
59,900
-60,500
-50% -$2.88M ﹤0.01% 4733
2024
Q2 		$5.93M Buy
120,400
+61,700
+105% +$2.52M ﹤0.01% 3178
2024
Q1 		$2.01M Sell
58,700
-48,600
-45% -$1.75M ﹤0.01% 5330
2023
Q4 		$3.96M Buy
107,300
+38,400
+56% +$888K ﹤0.01% 4115
2023
Q3 		$1.4M Sell
68,900
-14,800
-18% -$325K ﹤0.01% 5894
2023
Q2 		$1.71M Sell
83,700
-51,000
-38% -$764K ﹤0.01% 5477
2023
Q1 		$2.03M Buy
134,700
+74,600
+124% +$1.65M ﹤0.01% 5107
2022
Q4 		$1.43M Sell
60,100
-7,800
-11% -$226K ﹤0.01% 5395
2022
Q3 		$2.39M Buy
67,900
+1,800
+3% +$76.4K ﹤0.01% 4566
2022
Q2 		$2.31M Buy
66,100
+40,500
+158% +$1.43M ﹤0.01% 4612
2022
Q1 		$1.26M Sell
25,600
-6,200
-19% -$344K ﹤0.01% 6555
2021
Q4 		$2.46M Sell
31,800
-69,500
-69% -$7.13M ﹤0.01% 5033
2021
Q3 		$10.8M Buy
101,300
+20,600
+26% +$2.36M ﹤0.01% 2746
2021
Q2 		$10.8M Sell
80,700
-7,400
-8% -$860K ﹤0.01% 2812
2021
Q1 		$10.9M Sell
88,100
-6,900
-7% -$1.05M ﹤0.01% 2644
2020
Q4 		$13.4M Buy
95,000
+44,100
+87% +$4.89M ﹤0.01% 2150
2020
Q3 		$3.87M Buy
50,900
+27,000
+113% +$1.68M ﹤0.01% 3428
2020
Q2 		$1.08M Buy
23,900
+17,300
+262% +$621K ﹤0.01% 5735
2020
Q1 		$202K Buy
+6,600
New +$177K ﹤0.01% 8678

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Jeff Yass's TWST Position: Q2 2026 in Review

Jeff Yass reduced its Twist Bioscience (TWST) stake by 64% in Q2 2026, selling an estimated $3.74M and leaving 32,880 shares worth $3.38M. The position accounts for ﹤0.01% of the portfolio, ranked #5385.

Jeff Yass first reported a position in TWST in Q2 2019 and has held it in 28 quarters since. The position peaked at $7.37M in Q4 2020. 335 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Jeff Yass held 32,880 shares of Twist Bioscience worth $3.38M as of Q2 2026.
  • Jeff Yass sold 57,439 Twist Bioscience shares in Q2 2026, an estimated $3.74M.
  • Twist Bioscience made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #5385 holding.
  • Jeff Yass first reported a position in Twist Bioscience in Q2 2019 and has held it in 28 quarters since.
  • Jeff Yass's Twist Bioscience position peaked at $7.37M in Q4 2020.
  • 335 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.